Merli M - Search Results

1

Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis.

Merli M, Galli L, Marinaro L, Ariaudo A, Messina E, Uberti-Foppa C, Castagna A, D'Avolio A, Lazzarin A, Bonora S, Hasson H. Merli M, et al. J Antimicrob Chemother. 2017 Mar 1;72(3):812-815. doi: 10.1093/jac/dkw492. J Antimicrob Chemother. 2017. PMID: 27999010

2

HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study).

Hasson H, Galli L, Gallotta G, Neri V, Blanc P, D'Annunzio M, Morsica G, Sollima S, Merli M, Lazzarin A, Uberti-Foppa C. Hasson H, et al. Among authors: merli m. New Microbiol. 2012 Oct;35(4):469-74. Epub 2012 Oct 1. New Microbiol. 2012. PMID: 23109014 Free article. Clinical Trial.

3

Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus.

Bagaglio S, Messina E, Uberti-Foppa C, Merli M, Torre LD, Lazzarin A, Hasson H, Morsica G. Bagaglio S, et al. Among authors: merli m. J Antimicrob Chemother. 2013 Jun;68(6):1448-50. doi: 10.1093/jac/dkt019. Epub 2013 Feb 6. J Antimicrob Chemother. 2013. PMID: 23390206 No abstract available.

4

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.

Hasson H, Merli M, Galli L, Gallotta G, Carbone A, Messina E, Bagaglio S, Morsica G, Salpietro S, Castagna A, Lazzarin A, Uberti-Foppa C. Hasson H, et al. Among authors: merli m. Liver Int. 2013 Aug;33(7):1113-20. doi: 10.1111/liv.12159. Epub 2013 Mar 28. Liver Int. 2013. PMID: 23534616

5

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman.

Hasson H, Messina E, Merli M, Della Torre L, Morsica G, Bagaglio S, Lazzarin A, Uberti-Foppa C. Hasson H, et al. Among authors: merli m. Int J Infect Dis. 2014 Dec;29:100-2. doi: 10.1016/j.ijid.2014.08.011. Epub 2014 Oct 24. Int J Infect Dis. 2014. PMID: 25449243 Free article.

6

Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including Ribavirin.

Merli M, Messina E, Salpietro S, Lazzarin A, Uberti-Foppa C, Hasson H. Merli M, et al. Clin Infect Dis. 2016 Feb 15;62(4):527-8. doi: 10.1093/cid/civ902. Epub 2015 Oct 27. Clin Infect Dis. 2016. PMID: 26508514 No abstract available.

7

Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin.

Bagaglio S, Uberti-Foppa C, Di Serio C, Trentini F, Andolina A, Hasson H, Messina E, Merli M, Porrino L, Lazzarin A, Morsica G. Bagaglio S, et al. Among authors: merli m. Medicine (Baltimore). 2015 Oct;94(43):e1876. doi: 10.1097/MD.0000000000001876. Medicine (Baltimore). 2015. PMID: 26512601 Free PMC article. Clinical Trial.

8

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.

Di Maio VC, Cento V, Di Paolo D, Aragri M, De Leonardis F, Tontodonati M, Micheli V, Bellocchi MC, Antonucci FP, Bertoli A, Lenci I, Milana M, Gianserra L, Melis M, Di Biagio A, Sarrecchia C, Sarmati L, Landonio S, Francioso S, Lambiase L, Nicolini LA, Marenco S, Nosotti L, Giannelli V, Siciliano M, Romagnoli D, Pellicelli A, Vecchiet J, Magni CF, Babudieri S, Mura MS, Taliani G, Mastroianni C, Vespasiani-Gentilucci U, Romano M, Morisco F, Gasbarrini A, Vullo V, Bruno S, Baiguera C, Pasquazzi C, Tisone G, Picciotto A, Andreoni M, Parruti G, Rizzardini G, Angelico M, Perno CF, Ceccherini-Silberstein F; HCV Italian Resistance Network Study Group. Di Maio VC, et al. J Antimicrob Chemother. 2016 Mar;71(3):739-50. doi: 10.1093/jac/dkv403. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679249

9

Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment.

Bagaglio S, Andolina A, Merli M, Uberti-Foppa C, Morsica G. Bagaglio S, et al. Among authors: merli m. Viruses. 2016 Mar 25;8(4):91. doi: 10.3390/v8040091. Viruses. 2016. PMID: 27023593 Free PMC article.

10

Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.

Merli M, Galli L, Castagna A, Salpietro S, Gianotti N, Messina E, Poli A, Morsica G, Bagaglio S, Cernuschi M, Bigoloni A, Uberti-Foppa C, Lazzarin A, Hasson H. Merli M, et al. New Microbiol. 2016 Apr;39(2):110-3. New Microbiol. 2016. PMID: 27196548 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

664 results

Search Page

Filters